Defunct Company
Total Trials
23
As Lead Sponsor
11
As Collaborator
12
Total Enrollment
31,732
NCT01422317
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
Phase: Phase 3
Role: Collaborator
Start: Sep 30, 1995
Completion: Dec 31, 2002
NCT00010868
Omega-3 Fatty Acids in Bipolar Disorder
Phase: Phase 2
Start: Jul 31, 2000
Completion: Jul 31, 2004
NCT00257283
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
Phase: Phase 4
Role: Lead Sponsor
Start: Nov 30, 2002
Completion: Jun 30, 2005
NCT00294216
Omacor and Placebo in Carotid Plaque Stability
Start: Aug 31, 2003
Completion: Jul 31, 2005
NCT00251134
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
Start: Oct 31, 2003
Completion: Sep 30, 2008
NCT00360906
Omega-3 Fatty Acid Treatment in Multiple Sclerosis
Phase: Phase 2/3
Start: Dec 31, 2004
Completion: Jul 31, 2008
NCT00296153
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
Start: Feb 28, 2006
Completion: Oct 31, 2007
NCT01169259
Vitamin D and Omega-3 Trial (VITAL)
Start: Jul 31, 2010
Completion: May 31, 2026
NCT01813006
Effect of Omega-3 Fatty Acid on Endothelial Function
Start: Mar 31, 2013
Completion: Dec 31, 2017
NCT01893515
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
Start: Jul 31, 2013
Completion: Jul 31, 2014
NCT01972178
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Start: Nov 30, 2013
Completion: Aug 31, 2014
NCT01744067
The Effects of Omega-3 Fatty Acids in Renal Transplantation
Completion: Dec 31, 2015
NCT01813110
Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
Phase: N/A
Start: May 31, 2014
Completion: Apr 30, 2015
NCT02373176
[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study
Phase: Phase 1
Start: Jul 31, 2014
Completion: Sep 30, 2014
NCT02367937
PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study
Start: Aug 31, 2014
Completion: Oct 31, 2014
NCT02376608
Bioavailability of Omega-3 Food Supplement in Healthy Subjects
NCT02376621
Bioavailability of Omega-3 Food Supplements in Healthy Subjects
Start: Oct 31, 2014
Completion: Dec 31, 2014
NCT02364635
Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects
Start: Feb 28, 2015
Completion: Aug 31, 2015
NCT02923804
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
Start: Oct 31, 2015
Completion: Dec 1, 2017
NCT02661698
Plasma Diurnal Variation in and Absorption of EPA and DHA
Start: Feb 29, 2016
Completion: Oct 31, 2016
NCT03158545
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults
Start: Oct 10, 2016
Completion: Sep 4, 2017
NCT02763514
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
Start: Oct 31, 2016
Completion: Nov 30, 2018
NCT03018041
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
Start: Sep 1, 2017
Completion: Mar 22, 2025